EVEROLIMUS
everolimus 3 mg dispersible tablet, 30
EVEROLIMUS (11599L)
11599L
Manner of administration:Oral
Restriction
Indication: Refractory seizures associated with tuberous sclerosis complex
Treatment phase: Initial treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 1 | Max qty units: 30 | # of repeats: 5 | DPMQ: $548.32 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Afinitor | |||||